7#- 5, 4 4 4 4 4 4.J4x4x4x4x 444L4x4x5V 5v5*54 55555555555 References

Let's Play PET References - "H"

[Back to Menu] [Back to Index]
  • Haberkorn, U, Strauss, L, Kimitrakopoulou, A, et al: PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med, 32:1485-1490, 1991.

  • Haberkorn, U, Strauss, LG, Reisser, CH. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry. J. Nucl. Med., 32:1548-1554, 1991.

  • Halldin C, Farde L, Hogberg T, Hall H, Sedvall G. Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET. Int J Radiat Appl Instr A Appl Rad Isotopes, 41:669-74, 1990.

  • Harney JV; Wahl RL; Liebert M; Kuhl DE; Hutchins GD; Wedemeyer G; Grossman HB. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. J Urology, 1991, 145:279-83.

  • Hatazawa, J, Ishiwata, K, Itoh, M, Kameyama, M, Kubota, K, et al: Quantitative evaluation of L-[methyl-C-11]methionine uptake in tumor using positron emission tomography. J Nucl Med, 30:1809-13, 1989.

  • Hawkins, R, Choi, Y, Huang, S, Hoh, C, Dahlbom, M, Schiepers, C, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med, 33:633-42, 1992.

  • Hawkins, RA, Choi, Y, Huang, SC, Messa, C, Hoh, CK, Phelps, ME. Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med, 33:339-344, 1992.

  • Hawkins RA; Choi Y; Scates S; Rege S; Hoh CK; Glaspy J; Phelps ME. An animal model for in vivo evaluation of tumor glycolytic rates with positron emission tomography. J Surg Oncol, 1993, 53:104-9.

  • Hawkins, RA, Hoh, CK, Dahlbom, M, Choi, Y, Glaspy, J, Tse, N, Slamon, D, Chen, B, Messa, C, Maddahi, J, Phelps, ME. PET cancer evaluations with FDG. J. Nucl. Med., 32:1555-1558.

  • Hawkins, R, Hoh, C., Glaspy, J., Choi, Y., Dahlbom, M., Rege, S., Messa, C., Nietszche, E., Hoffman, E., Seeger, L., Maddahi, J., & Phelps, M. E. (1992). The role of positron emission tomography in oncology and other whole-body applications. Sem Nucl Med, 22, 268-284.

  • Hawkins R, Huang S, Barrio J, Keen R, Feng D, Mazziotta J, Phelps M. Estimation of local cerebral protein synthesis rates with L-[1-11C]leucine and PET: methods, model, and results in animals and humans. J Cereb Blood Flow Metab, 9:446-60, 1989.

  • Hawkins, R, Phelps, M, Huang, S: Effects of temporal sampling, glucose metabolic rates and disruptions of the blood brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumours with PET. J Cereb Blood Flow Metab, 6:170-83, 1986.

  • Haxby, J, Duara, R, Grady, C, Cutler, N, Rapoport, S: Relations between neuropsychological and cerebral asymmetries in early Alzheimer's disease. J Cereb Blood Flow Metab, 5:193-200, 1985.

  • Haxby J; Grady C; Horwitz B; Ungerleider L; Mishkin M; Carson R; Herscovitch P; Schapiro M; Rapoport S. Dissociation of object and spatial visual processing pathways in human extrastriate cortex. Proc Natl Acad Sci USA, 88:1621-5, 1991.

  • Haxby, JV, Grady, CL, Duara, R, Schlageter, N, Berg, G, Rapoport, SI: Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's type dementia. Arch Neurol, 43:882-885, 1986.

  • Hayden, M, Martin, W, Stoessl, A, et al. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology 36:888-94, 1986.

  • Heiss, WD, Heindel, W, Herholz, K, Rudolf, J, Bunke, J, Jeske, J, Friedmann, G: Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors. J Nucl Med, 31:302-310, 1990.

  • Heiss W; Pawlik G; Holthoff V; Kessler J; Szelies B. PET correlates of normal and impaired memory functions. Cerebrovasc Brain Metab Rev, 4:1-27, 1992.

  • Heiss, W, Szelies, B, Adams, R, Kessler, J, Pawlik, G, Herholz, K. PET criteria for diagnosis of Alzheimer's disease and other dementias. In K Maurer, P Riederer and H Beckmann, Eds., Alzheimers Disease: Epidemiology, Neuropathology, Neurochemistry, and Clinics, Springer-Verlag, Berlin, 1990, pp.473-87.

  • Henry, T, Engel, J Jr, Babbs, T, Phelps, M. Correlation of neuronal cell loss with degreee of interictal focal temporal hypometabolism in complex partial epilepsy. Neurology, 38(Suppl 1):156, 1988.

  • Henry, T, Mazziotta, J, Engel, J. Interictal metabolic anatomy of mesial temporal lobe epilepsy. Arch Neurol, 50:582-9, 1993.

  • Henze, E, Huang, S, Ratib, O, Hoffman, E, Phelps, M and Schelbert, H: Quantitative compensation for cross-contamination of positron emission computed tomographs from cardiac studies with C-11 palmitate. Nucl Med CompAssist Funct Anal, 200-203, 1982.

  • Henze, E, Schelbert, H, Barrio, J, Egbert, J, Hansen, H, MacDonald, N, et al.: Evaluation of Myocardial Metabolism with N-13 and C-11 Labeled Amino Acids for Positron Computed Tomography. J Nucl Med, 23:671-681, 1982.

  • Herrero P, Markham J, Shelton M, Bergmann S. Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. Circ Res, 70:496-507, 1992.

  • Herrero P; Markham J; Shelton M; Weinheimer C; Bergmann S. Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. Circulation, 1990, 82:1377-86.

  • Herrero P, Markham J, Weinheimer C, Anderson C, Welch M, Green M, Bergmann S. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography. Circulation, 87:173-83, 1993.

  • Herscovitch, P, Raichle, M, Kilbourn, M, Welch, M: Positron emission tomographic measurement of cerebral blood flow and permeability-surface are product of water using 15O-water and 11C-butanol. J Cereb Blood Flow Metab, 7:527-42, 1987.

  • Higashi, K, Clavo, A, Wahl, R. Invitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med, 34:773-9, 1993.

  • Hoff S; Stewart J; Frist W; Kessler R; Sandler M; Atkinson J; Votaw J; Carey J; Ansari M; Merrill W. Noninvasive detection of heart transplant rejection with positron emission scintigraphy. Ann of Thoracic Surg, 1992, 53:572-7.

  • Hoffman, E. J., Guerrero, T. M., Germano, G., Digby, W. M., & Dahlbom, M. (1989). PET system calibrations and corrections for quantitative and spatially accurate images. IEEE Trans Nucl Sci NS 36, 1108-1112.

  • Hoffman J; Coleman R. Perfusion quantitation using positron emission tomography. Invest Radiol, 1992, 27 Suppl 2:S22-6.

  • Hoffman, JM, Guze, BH, Baxter, LR, Mazziotta, JC, Phelps, ME: [18F]fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies. Eur. Neurol., 29 Suppl 3:16-24, 1989.

  • Hoffman, J, Melega, W, Hawk, T, Grafton, S, Luxen, A, Mahoney, D, et al. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. J Nucl Med, 33:1472-7, 1992.

  • Hoffman, J, Waskin, H, Schifter, T, Hanson, M, Gray, L, Rosenfeld, S, Coleman, R: FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med, 34:567-575, 1993.

  • Holthoff, V, Koeppe, R, Frey, K, Penney, J, Markel, D, Kuhl, D, Young, A. Positron emission tomography measures of benzodiazepine receptors in Huntingtons disease. Ann Neurol, 34: 76-81, 1993.

  • Hopfensperger, K, Koller, W: Recognizing early Parkinson's disease. Postgrad. Med., 90:49-59.

  • Hoyer, S. Changes in brain energy metabolism and the early detection of Alzheimers disease. In: Early Markers in Parkinsons and Alzheimers Diseases, 1990, pp. 233-44.

  • Huang, S, Barrio, J, Yu, D, Chen, B, Grafton, S, Melega, W, et al. Modelling approach for separating blood time-activity curves in positron emission tomographic studies. Phys Med Biol, 36:749-61, 1991.

  • Huang, S, Carson, R, Hoffman, E, Carson, J, Barrio, J, MacDonald, N, Phelps, M. Quantitative measurement of local cerebral blood flow in man with positron computed tomography and clearance of O-15 water. J Cereb Blood Flow Metab 3:141-53, 1983.

  • Huang, S, Phelps, M. Principles of tracer kinetic modeling in positron emission tomography. In Phelps, M, Mazziotta, J, Schelbert, H (Eds.): Positron Emission Tomography and Autoradiography. Raven, NY, 1986, pp. 287-346.

  • Huang, SC, Schwaiger, M, Carson, R, Carson, J, Hansen, H, Selin, C, et al.: Quantitative measurement of myocardial blood flow with oxygen-15 water and positron computed tomography: an assessment of potential and problems. J Nucl Med , 26:616-25, 1985.

  • Huang, S, William, B, Araujo, L, Nienaber, C, Selin, C, et al. Investigation of Rb-82 tissue kinetics and a compartmental model for the measurement of regional myocardial blood flow (MBF) with PET. J Nucl Med, 28:558, 1987.

  • Huang, S, Yu, D, Barrio, J, Grafton, S, Melega, W, et al. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies. J Cereb Blood Flow Metab, 11:898-913, 1991.

  • Hume S; Myers R; Bloomfield P; Opacka-Juffry J; Cremer J; Ahier R; Luthra S; Brooks D; Lammertsma A. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse, 12:47-54, 1992.

  • Hutchins, G, Schwaiger, M, Rosenspire, K, Krivokapich, J, Schelbert, H, Kuhl, D: Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol, 15:1032-42, 1990.

  • Hwang D, Dence C, McKinnon Z, Mathias C, Welch M. Positron labeled muscarinic acetylcholine receptor antagonist: 2- and 4-[18F]fluorodexetimide. Syntheses and biodistribution. Int J Radiat Appl Instr B Nucl Med Biol, 18:247-52, 1991.

  • Hwang D, Eckelman W, Mathias C, Petrillo E Jr, Lloyd J, Welch M. Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: fluorine-18-fluorocaptopril. Probing the ACE activity in vivo by positron emission tomography. J Nucl Med, 32:1730-7, 1991.

  • Hwang D, Mathias C, Welch M, McGuire A, Kadmon D. Imaging prostate derived tumors with PET and N-(3-[18F]fluoropropyl)putrescine. Int J Radiat Appl Instr B Nucl Med Biol, 17:525-32, 1990.

    Let's Play PET, Copyright 1992, 1993 Regents of the University of California
    All Rights Reserved

    [Back to Menu] [Back to Index]